Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Creative Medical Technologies Filed U.S. Patent Application #20240002792: Repair Of Ovarian Damage And Dampening Of Inflammatory Microenvironment By Administration Of Monocytic-granulocytic Progenitors With Immune Modulatory Activities

Author: Charles Gross | January 04, 2024 06:50am

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240002792

Posted In: CELZ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist